Work

Belzutifan for renal cell carcinoma: Balancing regulatory approval with societal and patient impact

Year: 2025

Type: article

Source: Med

DOI: 10.1016/j.medj.2024.11.016

Authors: Jad Chahoud, Pavlos Msaouel

Institutions: Moffitt Cancer Center, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4406270175

FWCI: 1.186

Cites: 10

Cited by: 2

Related to: 10